Manulife (Manufacturers Life Insurance)
PRDS

Manulife (Manufacturers Life Insurance)’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-44,071
Closed -$87.6K – 3016
2022
Q3 		$87.6K Sell
44,071
-28,093
-39% -$83.8K ﹤0.01% 2848
2022
Q2 		$217K Sell
72,164
-9,911
-12% -$60.5K ﹤0.01% 2614
2022
Q1 		$613K Buy
+82,075
New +$807K ﹤0.01% 2061

Other funds holding PRDS

FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PRDS Position: Q4 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q4 2022, closing a stake of 44,071 shares — an estimated $87.6K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PRDS in Q1 2022 and held it in 3 quarters. The position peaked at $613K in Q1 2022. 65 funds tracked by Wall St. Rank hold PRDS as of Q4 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 44,071 Pardes Biosciences, Inc. Common Stock shares in Q4 2022, an estimated $87.6K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Manulife (Manufacturers Life Insurance)'s Pardes Biosciences, Inc. Common Stock position peaked at $613K in Q1 2022.
  • 65 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q4 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.